Page last updated: 2024-08-25

4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene and cyclopentane

4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene has been researched along with cyclopentane in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hirao-Suzuki, M; Nagase, K; Shigemori, E; Suemori, T; Sugihara, N; Takeda, S; Takiguchi, M; Tanaka, M; Tsutsumi, K; Yoshihara, S1

Other Studies

1 other study(ies) available for 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene and cyclopentane

ArticleYear
4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Cyclopentanes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Estrogen Receptor beta; Female; Humans; MCF-7 Cells; Phenols; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction

2021